Principal Technologies (FRA:JO7) Total Receivables: €0.32 Mil (As of Apr. 2026)


FRA:JO7 Principal Technologies Inc FRA:JO7
4 GF Score
Price €0.22
GF Value €0.04
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Principal Technologies Total Receivables?

Principal Technologies FRA:JO7 +12.82% 4 Total Receivables is €0.32 Mil as of Apr. 2026. GuruFocus rates FRA:JO7 with a GF Score™ of 4/100 and a GF Value™ of €0.04 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Principal Technologies's Total Receivables for the quarter that ended in Apr. 2026 was €0.32 Mil.

Principal Technologies Total Receivables Related Terms

Principal Technologies Total Receivables Historical Data

* Premium members only.

The historical data trend for Principal Technologies's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Principal Technologies Total Receivables Chart

Principal Technologies Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Total Receivables
Get a 7-Day Free Trial 0.00 0.05 0.11 0.08 0.08

Principal Technologies Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.08 0.05 0.01 0.32
FRA:JO7
4GF Score
Principal Technologies Inc FRA:JO7
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Principal Technologies Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €0.32 Mil mean?
Principal Technologies (FRA:JO7) has a Total Receivables of €0.32 Mil as of Apr. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Principal Technologies and its competitors.
Is Principal Technologies' Total Receivables too high?
Principal Technologies' current Total Receivables is €0.32 Mil. Overall, Principal Technologies has a GF Score™ of 4/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Principal Technologies' Total Receivables compare to VEEV and BTSG?
Principal Technologies' Total Receivables of €0.32 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Healthcare Providers & Services company?
A good Total Receivables depends on the Healthcare Providers & Services industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Principal Technologies and its competitors. Principal Technologies's current Total Receivables is €0.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Principal Technologies stock overvalued right now?
Based on GuruFocus' analysis, Principal Technologies (FRA:JO7) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.04, compared to a current price of €0.22 — trading 450% above its estimated fair value. The current Total Receivables is €0.32 Mil. Principal Technologies' overall GF Score™ is 4/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Principal Technologies (FRA:JO7), the current Total Receivables is €0.32 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Principal Technologies (FRA:JO7) Overvalued in 2026?

Based on GuruFocus' analysis, Principal Technologies stock appears to be overvalued. The current stock price of €0.22 is trading 450% above its estimated GF Value™ of €0.04. GuruFocus considers Principal Technologies to be Significantly Overvalued.

Key valuation signals for FRA:JO7:

  • Total Receivables: €0.32 Mil
  • GF Value™: €0.04 vs. price of €0.22 (450% above fair value)
  • GF Score™: 4/100 with 7 warning signs

No single metric tells the full story. See the FRA:JO7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Principal Technologies Business Description

Other Exchanges PTEC:Canada
Address 700 West Georgia Street, Suite 2500, Vancouver, BC, CAN, V7Y 1B3
Principal Technologies Inc is in the research and development stage of building a portfolio of medical technology assets with a focus on distribution potential and intellectual property capable of enhancing medical treatment, cost efficiency, and optimization of the patient pathway. The company focuses on acquiring medical technology research and development assets or developing them jointly with industry leaders. Its current revenue-generating activities are attributable to E&E CRO Consulting GmbH, which provides clinical research advisory services. The company operates in one reportable operational segment, consisting of project management of clinical studies and research related to medical device technologies.
4GF Score

Get the complete analysis for FRA:JO7

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.22
Price
€0.04
GF Value